Cargando…

Managing interventional clinical trials in the setting of COVID-19: Experience in an autoimmune skin disease unit

Detalles Bibliográficos
Autores principales:	Borucki, Robert, Concha, Josef Symon S., Burroughs, Julie, Okawa, Joyce, Werth, Victoria P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Editorials/Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754881/ https://www.ncbi.nlm.nih.gov/pubmed/33733244 http://dx.doi.org/10.1016/j.jdin.2020.11.002

Ejemplares similares

Alopecias in lupus erythematosus
por: Concha, Josef Symon Salgado, et al.
Publicado: (2018)

Autoimmune Skin Disease Exacerbations Following COVID-19 Vaccination
por: Sprow, Grant, et al.
Publicado: (2022)

The CLASI, a validated tool for the evaluation of skin disease in lupus erythematosus: a narrative review
por: Chakka, Srita, et al.
Publicado: (2021)

AB004. Evaluating differences in meaningful change in disease activity between different races and clinical subtypes affected by cutaneous lupus erythematosus
por: Chakka, Srita, et al.
Publicado: (2021)

AB005. Assessing meaningful changes in disease activity as clinical trial clinical efficacy measures for cutaneous lupus erythematosus
por: Chakka, Srita, et al.
Publicado: (2021)

Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo effects of Lenabasum(TM)
por: Maddukuri, Spandana, et al.
Publicado: (2022)

Correction to: Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo efects of Lenabasum(TM)
por: Maddukuri, Spandana, et al.
Publicado: (2022)

AB014. Developing classification criteria for skin-predominant dermatomyositis: assessing the methodology of the prospective validation study
por: Concha, Josef Symon S., et al.
Publicado: (2021)

Towards Understanding Mechanisms of Autoimmune Bullous Skin Diseases
por: Krol, Rafal P, et al.
Publicado: (2013)

Potential allergenicity of commonly sold high SPF broad spectrum sunscreens in the United States; from the perspective of patients with autoimmune skin disease()()
por: Keyes, Emily, et al.
Publicado: (2019)

Autoimmunity Diseases of the Skin
por: Carvalho, Jozélio Freire, et al.
Publicado: (2013)

260 Responses following COVID-19 vaccination in patients with autoimmune skin disease
por: Sprow, G., et al.
Publicado: (2022)

Cutaneous lupus concerns from the patient perspective: a qualitative study
por: Yan, Daisy, et al.
Publicado: (2021)

Simulcast: a case study in the establishment of a virtual community of simulation practice
por: Symon, Benjamin, et al.
Publicado: (2020)

Comments on “Anatomically distinct fibroblast subsets determine skin autoimmune patterns”
por: Chen, Yudi, et al.
Publicado: (2022)

A Review of the Immunologic Pathways Involved in Bullous Pemphigoid and Novel Therapeutic Targets
por: Afarideh, Mohsen, et al.
Publicado: (2022)

Shedding Light on Skin Autoimmunity: More than Just Skin Deep
por: Li, Philip Hei, et al.
Publicado: (2023)

Deciphering the Footprints of Autoimmunity in CNS Demyelinating Disorders
por: Netravathi, M
Publicado: (2022)

Some Misconceptions about Understanding Autoimmunity through Experiments with Knockouts
por: Steinman, Lawrence
Publicado: (1997)

Central Nervous System (CNS) and Systemic Autoimmune Disease: Coexistence or More?
por: Vibha, Deepti, et al.
Publicado: (2022)

Nonmelanoma Skin Cancer on the Rise
por: Wollina, Uwe
Publicado: (2012)

Development of a working core outcome set for cutaneous lupus erythematosus: a practical approach to an urgent unmet need
por: Guo, Lisa N, et al.
Publicado: (2021)

SLE - Complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosus
por: Aringer, Martin, et al.
Publicado: (2003)

Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: experience from an Italian skin cancer unit
por: Quaglino, Pietro, et al.
Publicado: (2021)

Why rheumatologic skin disease?
por: Sontheimer, Richard D., et al.
Publicado: (2021)

Candidate drug replacements for quinacrine in cutaneous lupus erythematosus
por: Yan, Daisy, et al.
Publicado: (2020)

Interventional Pain Management: Need of the Hour for Cancer Pain Patients
por: Bhatnagar, Sushma
Publicado: (2009)

Amalgamation of technology, advance trachea-carinal plasty technique, extensive non-intubated thoracic surgery experience and knowledge: the jigsaw pieces all coming together?
por: Ng, Calvin S. H., et al.
Publicado: (2021)

Skin, Autoimmunity and Inflammation: A Comprehensive Exploration through Scientific Research
por: Diotallevi, Federico, et al.
Publicado: (2023)

Development of outcome measures for autoimmune dermatoses
por: Gaines, Elizabeth, et al.
Publicado: (2007)

Operational Research in Health-care Settings
por: Kunwar, Rajesh, et al.
Publicado: (2019)

Advancing Transition in Resource-Constrained Settings
por: Sinnappurajar, Praisoody, et al.
Publicado: (2022)

Lupus skin disease
por: Werth, Victoria P
Publicado: (2014)

Age-related autoimmunity
por: Vadasz, Zahava, et al.
Publicado: (2013)

Is atherosclerosis an autoimmune disease?
por: Matsuura, Eiji, et al.
Publicado: (2014)

Liver Diseases and Autoimmunity
por: Xia, Harry Hua-Xiang
Publicado: (2013)

Targeting fibrocytes in autoimmunity
por: Bucala, Richard J.
Publicado: (2022)

The content, experiences and outcomes of interventions designed to increase early skin‐to‐skin contact in high‐income settings: A mixed‐methods systematic review
por: Moran, Chloe, et al.
Publicado: (2022)

Bridging The Gap in Epilepsy Treatment in A Resource-Limited Setting
por: Keni, Ravish R., et al.
Publicado: (2020)

Cognitive Screening Tools for Adults in Indian Setting: A Commentary
por: Chakravarty, Kamalesh, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qv1lblcu0obebat8750sfdq3vc